Rakovina Therapeutics Inc.
RKV.V
TSX
| 09/30/2025 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 40.77% | 40.77% | -37.93% | -37.93% | -42.89% |
| Total Depreciation and Amortization | 1.55% | 1.55% | 4.89% | 4.89% | -4.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,098.58% | 1,098.58% | -83.22% | -83.22% | 183.90% |
| Change in Net Operating Assets | 124.85% | 124.85% | -154.98% | -154.98% | 213.67% |
| Cash from Operations | 65.66% | 65.66% | -153.96% | -153.96% | 31.44% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 94.09% | 94.09% | -- | -- | -- |
| Cash from Financing | -100.53% | -100.53% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -158.95% | -158.95% | 251.54% | 251.54% | -214.07% |